{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:58:36Z","timestamp":1792447116922,"version":"4.5.0"},"reference-count":352,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1124\/pr.117.014449","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T13:55:24Z","timestamp":1538402124000},"page":"836-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":217,"title":["International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans"],"prefix":"10.1016","volume":"70","author":[{"given":"Werner","family":"Sieghart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav M.","family":"Savi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.117.014449_bib1","doi-asserted-by":"crossref","first-page":"5746","DOI":"10.1016\/j.bmcl.2009.07.153","article-title":"Discovery of the imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepine scaffold as a novel, potent and selective GABA(A) alpha5 inverse agonist series","volume":"19","author":"Achermann","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.014449_bib2","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1111\/bph.13350","article-title":"The Concise Guide to Pharmacology 2015\/16: ligand-gated ion channels","volume":"172","author":"Alexander","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib3","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bmc.2011.03.035","article-title":"Development and SAR of functionally selective allosteric modulators of GABAA receptors","volume":"19","author":"Alhambra","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fncel.2015.00275","article-title":"An excitatory GABA loop operating in vivo","volume":"9","author":"Astorga","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pr.117.014449_bib5","series-title":"GABA and Sleep, Molecular, Functional and Clinical Aspects","first-page":"25","article-title":"Development of subtype-selective GABAA receptor compounds for the treatment of anxiety, sleep disorders and epilepsy.","author":"Atack","year":"2010"},{"key":"10.1124\/pr.117.014449_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pharmthera.2009.09.001","article-title":"Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA","volume":"125","author":"Atack","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.117.014449_bib7","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuropharm.2006.04.018","article-title":"L-655,708 enhances cognition in rats but is not proconvulsant at a dose selective for alpha5-containing GABAA receptors","volume":"51","author":"Atack","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1476-5381.2009.00216.x","article-title":"The plasma-occupancy relationship of the novel GABAA receptor benzodiazepine site ligand, alpha5IA, is similar in rats and primates","volume":"157","author":"Atack","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib9","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0269881109354928","article-title":"Preclinical and clinical pharmacology of TPA023B, a GABAA receptor alpha2\/alpha3 subtype-selective partial agonist","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.117.014449_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bjp.0706056","article-title":"Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors","volume":"144","author":"Atack","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib11","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1124\/jpet.109.157636","article-title":"In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist","volume":"331","author":"Atack","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib12","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/0269881109354927","article-title":"MRK-409 (MK-0343), a GABAA receptor subtype-selective partial agonist, is a non-sedating anxiolytic in preclinical species but causes sedation in humans","volume":"25","author":"Atack","year":"2011","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.117.014449_bib13","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","article-title":"TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates","volume":"316","author":"Atack","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.109.157909","article-title":"Benzodiazepine binding site occupancy by the novel GABAA receptor subtype-selective drug 7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine (TPA023) in rats, primates, and humans","volume":"332","author":"Atack","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib15","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-008-1357-7","article-title":"RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors","volume":"202","author":"Ballard","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of \u03b3-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.117.014449_bib17","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1471-4159.1991.tb11443.x","article-title":"gamma-Aminobutyric acidA receptor heterogeneity is increased by alternative splicing of a novel beta-subunit gene transcript","volume":"56","author":"Bateson","year":"1991","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib352","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.euroneuro.2018.05.014","article-title":"Attaining in vivo selectivity of positive modulation of \u03b13\u03b2\u03b32 GABA(A) receptors in rats: A hard task!","volume":"28","author":"Batini\u0107","year":"2018","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.117.014449_bib18","doi-asserted-by":"crossref","first-page":"36275","DOI":"10.1074\/jbc.M105240200","article-title":"Subunit arrangement of gamma-aminobutyric acid type A receptors","volume":"276","author":"Baumann","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/jnc.12270","article-title":"Molecular analysis of the site for 2-arachidonylglycerol (2-AG) on the \u03b22 subunit of GABA(A) receptors","volume":"126","author":"Baur","year":"2013","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib20","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1111\/j.1471-4159.2007.04982.x","article-title":"Replacement of histidine in position 105 in the \u03b15 subunit by cysteine stimulates zolpidem sensitivity of \u03b15\u03b22\u03b32 GABA(A) receptors","volume":"103","author":"Baur","year":"2007","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1124\/mol.105.011882","article-title":"Novel plant substances acting as beta subunit isoform-selective positive allosteric modulators of GABAA receptors","volume":"68","author":"Baur","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1038\/npp.2016.49","article-title":"A pharmacogenetic 'restriction-of-function' approach reveals evidence for anxiolytic-like actions mediated by alpha5-containing GABAA receptors in mice","volume":"41","author":"Behlke","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.014449_bib23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0028-3908(02)00172-7","article-title":"The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors","volume":"43","author":"Belelli","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrn1703","article-title":"Neurosteroids: endogenous regulators of the GABA(A) receptor","volume":"6","author":"Belelli","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.117.014449_bib25","doi-asserted-by":"crossref","first-page":"11031","DOI":"10.1073\/pnas.94.20.11031","article-title":"The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid","volume":"94","author":"Belelli","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib26","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2679-05.2005","article-title":"Extrasynaptic GABAA receptors of thalamocortical neurons: a molecular target for hypnotics","volume":"25","author":"Belelli","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib27","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1152\/jn.00227.2009","article-title":"Inhibitory transmission in locus coeruleus neurons expressing GABAA receptor epsilon subunit has a number of unique properties","volume":"102","author":"Belujon","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fncel.2012.00035","article-title":"Refuting the challenges of the developmental shift of polarity of GABA actions: GABA more exciting than ever!","volume":"6","author":"Ben-Ari","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pr.117.014449_bib29","doi-asserted-by":"crossref","first-page":"19613","DOI":"10.1074\/jbc.274.28.19613","article-title":"A significant part of native gamma-aminobutyric acidA receptors containing alpha4 subunits do not contain gamma or delta subunits","volume":"274","author":"Bencsits","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib30","doi-asserted-by":"crossref","first-page":"43654","DOI":"10.1074\/jbc.M407154200","article-title":"Analysis of the presence and abundance of GABAA receptors containing two different types of alpha subunits in murine brain using point-mutated alpha subunits","volume":"279","author":"Benke","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1471-4159.1997.69020806.x","article-title":"GABA(A) receptors containing the alpha4-subunit: prevalence, distribution, pharmacology, and subunit architecture in situ","volume":"69","author":"Benke","year":"1997","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib32","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0031-9384(87)90360-X","article-title":"Pharmacology of the pyrazolo-type compounds: agonist, antagonist and inverse agonist actions","volume":"41","author":"Bennett","year":"1987","journal-title":"Physiol Behav"},{"key":"10.1124\/pr.117.014449_bib33","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0014-5793(98)00803-5","article-title":"Pharmacology of recombinant gamma-aminobutyric acidA receptors rendered diazepam-insensitive by point-mutated alpha-subunits","volume":"431","author":"Benson","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.117.014449_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2210-8-11","article-title":"Pharmacological properties of DOV 315,090, an ocinaplon metabolite","volume":"8","author":"Berezhnoy","year":"2008","journal-title":"BMC Pharmacol"},{"key":"10.1124\/pr.117.014449_bib35","series-title":"Handbook of Contemporary Neuropharmacology","first-page":"465","article-title":"Pharmacology of the GABAA receptor","author":"Berezhnoy","year":"2007"},{"key":"10.1124\/pr.117.014449_bib36","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1152\/physrev.00036.2003","article-title":"Molecular structure and physiological functions of GABA(B) receptors","volume":"84","author":"Bettler","year":"2004","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.117.014449_bib37","doi-asserted-by":"crossref","first-page":"10934","DOI":"10.1523\/JNEUROSCI.23-34-10934.2003","article-title":"Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns","volume":"23","author":"Bianchi","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib38","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bmcl.2005.11.112","article-title":"Imidazo[1,2-a]pyrimidines as functionally selective GABA(A) ligands","volume":"16","author":"Blackaby","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.014449_bib39","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.neubiorev.2013.06.008","article-title":"The role of behavior in translational models for psychopathology: functionality and dysfunctional behaviors","volume":"37","author":"Blanchard","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1124\/pr.117.014449_bib40","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1038\/sj.emboj.7601309","article-title":"Synaptic GABAA receptors are directly recruited from their extrasynaptic counterparts","volume":"25","author":"Bogdanov","year":"2006","journal-title":"EMBO J"},{"key":"10.1124\/pr.117.014449_bib41","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1523\/JNEUROSCI.3751-05.2005","article-title":"Tandem subunits effectively constrain GABAA receptor stoichiometry and recapitulate receptor kinetics but are insensitive to GABAA receptor-associated protein","volume":"25","author":"Boileau","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib42","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1523\/JNEUROSCI.5039-09.2010","article-title":"The short splice variant of the gamma 2 subunit acts as an external modulator of GABA(A) receptor function","volume":"30","author":"Boileau","year":"2010","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.mcn.2007.12.011","article-title":"The promiscuous role of the epsilon subunit in GABAA receptor biogenesis","volume":"37","author":"Bollan","year":"2008","journal-title":"Mol Cell Neurosci"},{"key":"10.1124\/pr.117.014449_bib44","doi-asserted-by":"crossref","first-page":"9891","DOI":"10.1073\/pnas.96.17.9891","article-title":"theta, a novel gamma-aminobutyric acid type A receptor subunit","volume":"96","author":"Bonnert","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1038\/nn.4102","article-title":"Regulating anxiety with extrasynaptic inhibition","volume":"18","author":"Botta","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.117.014449_bib46","doi-asserted-by":"crossref","first-page":"20440","DOI":"10.1074\/jbc.M115.698860","article-title":"Comparison of \u03b3-aminobutyric acid, type A (GABAA), receptor \u03b1\u03b2\u03b3 and \u03b1\u03b2\u03b4 expression using flow cytometry and electrophysiology: evidence for alternative subunit stoichiometries and arrangements","volume":"291","author":"Botzolakis","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib47","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1046\/j.1471-4159.1998.70030899.x","article-title":"Expression of GABA receptor rho subunits in rat brain","volume":"70","author":"Boue-Grabot","year":"1998","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib48","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1073\/pnas.74.9.3805","article-title":"Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding","volume":"74","author":"Braestrup","year":"1977","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuron.2011.12.012","article-title":"Extrasynaptic GABA(A) receptors: their function in the CNS and implications for disease","volume":"73","author":"Brickley","year":"2012","journal-title":"Neuron"},{"key":"10.1124\/pr.117.014449_bib50","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human alpha(4)beta(3)delta GABA(A) receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib51","doi-asserted-by":"crossref","first-page":"5958","DOI":"10.1016\/j.bmcl.2009.08.027","article-title":"Imidazo[1,5-a][1,2,4]-triazolo[1,5-d][1,4]benzodiazepines as potent and highly selective GABAA alpha5 inverse agonists with potential for the treatment of cognitive dysfunction","volume":"19","author":"Buettelmann","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.014449_bib52","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1016\/j.bmcl.2006.03.081","article-title":"2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonists","volume":"16","author":"Carling","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.014449_bib53","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00001756-199603220-00023","article-title":"The agonistic action of pentobarbital on GABAA beta-subunit homomeric receptors","volume":"7","author":"Cestari","year":"1996","journal-title":"Neuroreport"},{"key":"10.1124\/pr.117.014449_bib54","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1021\/jm020582q","article-title":"Identification of a novel, selective GABA(A) alpha5 receptor inverse agonist which enhances cognition","volume":"46","author":"Chambers","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib55","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/j.1440-1681.2004.04083.x","article-title":"GABAC receptor ion channels","volume":"31","author":"Chebib","year":"2004","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1124\/pr.117.014449_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/srep28674","article-title":"Zolpidem is a potent stoichiometry-selective modulator of \u03b11\u03b23 GABAA receptors: evidence of a novel benzodiazepine site in the \u03b11-\u03b11 interface","volume":"6","author":"Che Has","year":"2016","journal-title":"Sci Rep"},{"key":"10.1124\/pr.117.014449_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-2999(99)00750-5","article-title":"Activation of rat locus coeruleus neuron GABA(A) receptors by propofol and its potentiation by pentobarbital or alphaxalone","volume":"386","author":"Chen","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib58","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2017.07.027","article-title":"Physiological and pharmacological properties of inhibitory postsynaptic currents mediated by \u03b15\u03b21\u03b32, \u03b15\u03b22\u03b32 and \u03b15\u03b23\u03b32 GABAA receptors","volume":"125","author":"Chen","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib59","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1111\/bph.14198","article-title":"Cerebellar \u03b16 -subunit-containing GABAA receptors: a novel therapeutic target for disrupted prepulse inhibition in neuropsychiatric disorders","volume":"175","author":"Chiou","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib60","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1152\/jn.00539.2013","article-title":"EEG-\u03b2\/\u03b3 spectral power elevation in rat: a translatable biomarker elicited by GABA(A\u03b12\/3)-positive allosteric modulators at nonsedating anxiolytic doses","volume":"113","author":"Christian","year":"2015","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib61","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1097\/00000542-200406000-00016","article-title":"Gamma-aminobutyric acid type A receptor beta 2 subunit mediates the hypothermic effect of etomidate in mice","volume":"100","author":"Cirone","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1124\/pr.117.014449_bib62","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09511","article-title":"Reducing excessive GABA-mediated tonic inhibition promotes functional recovery after stroke","volume":"468","author":"Clarkson","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib63","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2174\/092986707782360097","article-title":"An updated unified pharmacophore model of the benzodiazepine binding site on gamma-aminobutyric acid(a) receptors: correlation with comparative models","volume":"14","author":"Clayton","year":"2007","journal-title":"Curr Med Chem"},{"key":"10.1124\/pr.117.014449_bib64","article-title":"A review of the updated pharmacophore for the alpha 5 GABA(A) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int J Med Chem"},{"key":"10.1124\/pr.117.014449_bib65","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00213-006-0361-z","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors improves encoding and recall but not consolidation in the Morris water maze","volume":"188","author":"Collinson","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib66","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","article-title":"Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor","volume":"22","author":"Collinson","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib67","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/j.1460-9568.2005.04127.x","article-title":"Loss of zolpidem efficacy in the hippocampus of mice with the GABAA receptor gamma2 F77I point mutation","volume":"21","author":"Cope","year":"2005","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib68","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2174\/156802612799078720","article-title":"Translocator protein as a promising target for novel anxiolytics","volume":"12","author":"Costa","year":"2012","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pr.117.014449_bib69","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1016\/0006-2952(85)90709-9","article-title":"Endogenous ligands for benzodiazepine recognition sites","volume":"34","author":"Costa","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib70","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0165-6147(96)10015-8","article-title":"Benzodiazepines on trial: a research strategy for their rehabilitation","volume":"17","author":"Costa","year":"1996","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.117.014449_bib71","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib72","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0026-895X(24)12233-X","article-title":"Molecular targets for the myorelaxant action of diazepam","volume":"59","author":"Crestani","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib73","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1073\/pnas.88.7.2673","article-title":"Cloning of the gamma-aminobutyric acid (GABA) rho 1 cDNA: a GABA receptor subunit highly expressed in the retina","volume":"88","author":"Cutting","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib74","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1755-5949.2009.00109.x","article-title":"A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder","volume":"16","author":"Czobor","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1124\/pr.117.014449_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/(SICI)1520-6769(199911\/12)25:3<139::AID-NRC3>3.0.CO;2-W","article-title":"Zaleplon displays a selectivity to recombinant GABAA receptors different from zolpidem, zopiclone and benzodiazepines","volume":"25","author":"D\u00e4mgen","year":"1999","journal-title":"Neurosci Res Commun"},{"key":"10.1124\/pr.117.014449_bib76","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0026-895X(24)23107-2","article-title":"Characterization of the interaction of zopiclone with gamma-aminobutyric acid type A receptors","volume":"58","author":"Davies","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib77","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/385820a0","article-title":"Insensitivity to anaesthetic agents conferred by a class of GABA(A) receptor subunit","volume":"385","author":"Davies","year":"1997","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib78","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/sj.bjp.0700987","article-title":"Modulation by general anaesthetics of rat GABAA receptors comprised of alpha 1 beta 3 and beta 3 subunits expressed in human embryonic kidney 293 cells","volume":"120","author":"Davies","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1469-7793.2001.0101k.x","article-title":"Evidence for the formation of functionally distinct alphabetagammaepsilon GABA(A) receptors","volume":"537","author":"Davies","year":"2001","journal-title":"J Physiol"},{"key":"10.1124\/pr.117.014449_bib80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0028-3908(02)00153-3","article-title":"Alternative transcripts of the GABA(A) receptor epsilon subunit in human and rat","volume":"43","author":"Davies","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib81","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1074\/jbc.M208814200","article-title":"A novel class of ligand-gated ion channel is activated by Zn2+","volume":"278","author":"Davies","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib82","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1124\/jpet.105.092320","article-title":"An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition","volume":"316","author":"Dawson","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib83","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1177\/0269881106072343","article-title":"Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers","volume":"21","author":"de Haas","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.117.014449_bib84","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopsycho.2006.01.006","article-title":"Extending animal models of fear conditioning to humans","volume":"73","author":"Delgado","year":"2006","journal-title":"Biol Psychol"},{"key":"10.1124\/pr.117.014449_bib85","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bcp.2014.12.010","article-title":"GABAA \u03b15 subunit-containing receptors do not contribute to reversal of inflammatory-induced spinal sensitization as indicated by the unique selectivity profile of the GABAA receptor allosteric modulator NS16085","volume":"93","author":"de Lucas","year":"2015","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib86","doi-asserted-by":"crossref","first-page":"10682","DOI":"10.1523\/JNEUROSCI.1166-05.2005","article-title":"Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines","volume":"25","author":"Dias","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib87","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.neuropharm.2010.11.026","article-title":"HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic pain","volume":"60","author":"Di Lio","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib88","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0026-895X(25)13276-8","article-title":"U-93631 causes rapid decay of gamma-aminobutyric acid-induced chloride currents in recombinant rat gamma-aminobutyric acid type A receptors","volume":"44","author":"Dillon","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib89","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1476-5381.1995.tb16368.x","article-title":"Enhancement by GABA of the association rate of picrotoxin and tert-butylbicyclophosphorothionate to the rat cloned alpha 1 beta 2 gamma 2 GABAA receptor subtype","volume":"115","author":"Dillon","year":"1995","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib90","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0022-3565(25)24354-3","article-title":"gamma-Aminobutyric acid gating of Cl- channels in recombinant GABAA receptors","volume":"272","author":"Duci\u0107","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib91","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1124\/mol.114.094813","article-title":"\u03b3-aminobutyric acid type A \u03b14, \u03b22, and \u03b4 subunits assemble to produce more than one functionally distinct receptor type","volume":"86","author":"Eaton","year":"2014","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.pbb.2008.01.021","article-title":"Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing","volume":"90","author":"Ebert","year":"2008","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.117.014449_bib93","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/mol.52.6.1150","article-title":"Differences in agonist\/antagonist binding affinity and receptor transduction using recombinant human gamma-aminobutyric acid type A receptors","volume":"52","author":"Ebert","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib94","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0026-895X(25)09839-6","article-title":"Molecular pharmacology of gamma-aminobutyric acid type A receptor agonists and partial agonists in oocytes injected with different alpha, beta, and gamma receptor subunit combinations","volume":"46","author":"Ebert","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib95","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1021\/jm011082k","article-title":"N-Substituted 4-amino-3,3-dipropyl-2(3H)-furanones: new positive allosteric modulators of the GABA(A) receptor sharing electrophysiological properties with the anticonvulsant loreclezole","volume":"45","author":"El Hadri","year":"2002","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib96","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14120","article-title":"Modulation of anxiety and fear via distinct intrahippocampal circuits","volume":"5","author":"Engin","year":"2016","journal-title":"eLife"},{"key":"10.1124\/pr.117.014449_bib97","doi-asserted-by":"crossref","first-page":"13698","DOI":"10.1523\/JNEUROSCI.1370-15.2015","article-title":"Tonic inhibitory control of dentate gyrus granule cells by \u03b15-containing GABAA receptors reduces memory interference","volume":"35","author":"Engin","year":"2015","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib98","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1523\/JNEUROSCI.16-14-04479.1996","article-title":"Immunocytochemical localization of the GABAc receptor rho subunits in the mammalian retina","volume":"16","author":"Enz","year":"1996","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib99","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/S0042-6989(97)00277-0","article-title":"Molecular composition of GABAC receptors","volume":"38","author":"Enz","year":"1998","journal-title":"Vision Res"},{"key":"10.1124\/pr.117.014449_bib100","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0306-4522(03)00288-4","article-title":"Comparative modeling of GABA(A) receptors: limits, insights, future developments","volume":"119","author":"Ernst","year":"2003","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib101","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1124\/mol.105.015982","article-title":"Comparative models of GABAA receptor extracellular and transmembrane domains: important insights in pharmacology and function","volume":"68","author":"Ernst","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib102","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13295-015-0016-9","article-title":"GABAA receptor subtypes: structural variety raises hope for new therapy concepts","volume":"6","author":"Ernst","year":"2015","journal-title":"e-Neuroforum"},{"key":"10.1124\/pr.117.014449_bib103","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/jn.90991.2008","article-title":"GABAA receptors containing gamma1 subunits contribute to inhibitory transmission in the central amygdala","volume":"101","author":"Esmaeili","year":"2009","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib104","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2017.08.012","article-title":"Selective inhibition of extra-synaptic \u03b15-GABAA receptors by S44819, a new therapeutic agent","volume":"125","author":"Etherington","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.117.014449_bib106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.phrs.2017.12.031","article-title":"Comparison of \u03b1\u03b2\u03b4 and \u03b1\u03b2\u03b3 GABAA receptors: allosteric modulation and identification of subunit arrangement by site-selective general anesthetics","volume":"133","author":"Feng","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1124\/pr.117.014449_bib107","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1476-5381.2011.01615.x","article-title":"Flavan-3-ol esters: new agents for exploring modulatory sites on GABA(A) receptors","volume":"165","author":"Fernandez","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib108","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.neuropharm.2008.06.069","article-title":"Flavan-3-ol derivatives are positive modulators of GABA(A) receptors with higher efficacy for the alpha(2) subtype and anxiolytic action in mice","volume":"55","author":"Fernandez","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib109","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuropharm.2010.08.011","article-title":"Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure","volume":"59","author":"Fischer","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2017.03.001","article-title":"Pharmacological and antihyperalgesic properties of the novel \u03b12\/3 preferring GABAA receptor ligand MP-III-024","volume":"131","author":"Fischer","year":"2017","journal-title":"Brain Res Bull"},{"key":"10.1124\/pr.117.014449_bib111","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0026-895X(24)12091-3","article-title":"Amiloride inhibition of gamma-aminobutyric acid(A) receptors depends upon the alpha subunit subtype","volume":"61","author":"Fisher","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib112","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.molpharmaceut.6b00159","article-title":"Development of GABAA receptor subtype-selective imidazobenzodiazepines as novel asthma treatments","volume":"13","author":"Forkuo","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.117.014449_bib113","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1213\/ANE.0000000000001368","article-title":"Mapping general anesthetic sites in heteromeric \u03b3-aminobutyric acid type A receptors reveals a potential for targeting receptor subtypes","volume":"123","author":"Forman","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1124\/pr.117.014449_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-007-0446-y","article-title":"Colocalization of synaptic GABA(C)-receptors with GABA (A)-receptors and glycine-receptors in the rodent central nervous system","volume":"330","author":"Frazao","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1124\/pr.117.014449_bib115","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.117.014449_bib116","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2174\/1568026023393525","article-title":"GABA(A) receptor ligands and their therapeutic potentials","volume":"2","author":"Fr\u00f8lund","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pr.117.014449_bib117","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejphar.2008.06.093","article-title":"6,3\u2032-Dinitroflavone is a low efficacy modulator of GABA(A) receptors","volume":"591","author":"Furtmueller","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib118","doi-asserted-by":"crossref","first-page":"L931","DOI":"10.1152\/ajplung.00107.2014","article-title":"Selective targeting of the \u03b15-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling","volume":"308","author":"Gallos","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1124\/pr.117.014449_bib119","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0959-440X(94)90218-6","article-title":"Neurotransmitter-gated ion channels as unconventional allosteric proteins","volume":"4","author":"Galzi","year":"1994","journal-title":"Curr Opin Struct Biol"},{"key":"10.1124\/pr.117.014449_bib120","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.neuropharm.2010.03.003","article-title":"Zolpidem modulation of phasic and tonic GABA currents in the rat dorsal motor nucleus of the vagus","volume":"58","author":"Gao","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib121","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0278-5846(92)90099-Z","article-title":"A review of recently-developed ligands for neuronal benzodiazepine receptors and their pharmacological activities","volume":"16","author":"Gardner","year":"1992","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.117.014449_bib122","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.euroneuro.2009.01.011","article-title":"Research in anxiety disorders: from the bench to the bedside","volume":"19","author":"Garner","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.117.014449_bib123","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1124\/jpet.109.161885","article-title":"Limiting activity at beta1-subunit-containing GABAA receptor subtypes reduces ataxia","volume":"332","author":"Gee","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib124","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.2174\/1381612819666131216114612","article-title":"The role of \u03b15 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia","volume":"20","author":"Gill","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.117.014449_bib125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.neuron.2007.11.002","article-title":"Activation of GABAA receptors: views from outside the synaptic cleft","volume":"56","author":"Glykys","year":"2007","journal-title":"Neuron"},{"key":"10.1124\/pr.117.014449_bib126","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1113\/jphysiol.2007.134460","article-title":"The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus","volume":"582","author":"Glykys","year":"2007","journal-title":"J Physiol"},{"key":"10.1124\/pr.117.014449_bib127","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/jm051065l","article-title":"Imidazo[1,2-a]pyrimidines as functionally selective and orally bioavailable GABA(A)alpha2\/alpha3 binding site agonists for the treatment of anxiety disorders","volume":"49","author":"Goodacre","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0924-977X(95)00072-W","article-title":"Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes","volume":"6","author":"Graham","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.117.014449_bib129","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/BF02244106","article-title":"Benzodiazepine concentrations in brain directly reflect receptor occupancy: studies of diazepam, lorazepam, and oxazepam","volume":"102","author":"Greenblatt","year":"1990","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0022-3565(24)29437-4","article-title":"SL651498: an anxioselective compound with functional selectivity for alpha2- and alpha3-containing gamma-aminobutyric acid(A) (GABA(A)) receptors","volume":"298","author":"Griebel","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib131","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1460-9568.2006.04890.x","article-title":"The role of GABAbeta2 subunit-containing receptors in mediating the anticonvulsant and sedative effects of loreclezole","volume":"24","author":"Groves","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib132","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1016\/j.bmc.2007.01.053","article-title":"Novel 3-iodo-8-ethoxypyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide as promising lead for design of alpha5-inverse agonist useful tools for therapy of mnemonic damage","volume":"15","author":"Guerrini","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib133","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/(SICI)1096-9861(19960212)365:3<504::AID-CNE12>3.0.CO;2-Q","article-title":"Immunocytochemical localization of the alpha 6 subunit of the gamma-aminobutyric acidA receptor in the rat nervous system","volume":"365","author":"Guti\u00e9rrez","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.117.014449_bib134","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0026-895X(25)13351-8","article-title":"Role of the beta subunit in determining the pharmacology of human gamma-aminobutyric acid type A receptors","volume":"44","author":"Hadingham","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib135","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1113\/jphysiol.2007.132886","article-title":"Rat alpha6beta2delta GABAA receptors exhibit two distinct and separable agonist affinities","volume":"581","author":"Hadley","year":"2007","journal-title":"J Physiol"},{"key":"10.1124\/pr.117.014449_bib136","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1460-9568.2000.00964.x","article-title":"Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy","volume":"12","author":"H\u00e1jos","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib137","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1046\/j.1460-9568.1999.00709.x","article-title":"Subunit-selective modulation of GABAA receptors by the non-steroidal anti-inflammatory agent, mefenamic acid","volume":"11","author":"Halliwell","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib138","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1742-7843.2009.00517.x","article-title":"Active-site concentrations of chemicals - are they a better predictor of effect than plasma\/organ\/tissue concentrations?","volume":"106","author":"Hammarlund-Udenaes","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/pr.117.014449_bib139","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/mol.115.099291","article-title":"A Multifaceted GABAA receptor modulator: functional properties and mechanism of action of the sedative-hypnotic and recreational drug methaqualone (Quaalude)","volume":"88","author":"Hammer","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0028-3908(03)00187-4","article-title":"The modulatory effects of the anxiolytic etifoxine on GABA(A) receptors are mediated by the beta subunit","volume":"45","author":"Hamon","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib141","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/bs.apha.2014.10.007","article-title":"Interactions of flavonoids with ionotropic GABA receptors","volume":"72","author":"Hanrahan","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.117.014449_bib142","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1021\/jm701433b","article-title":"Selective influence on contextual memory: physiochemical properties associated with selectivity of benzodiazepine ligands at GABAA receptors containing the alpha5 subunit","volume":"51","author":"Harris","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib143","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bcp.2015.12.021","article-title":"High and low GABA sensitivity \u03b14\u03b22\u03b4 GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries","volume":"103","author":"Hartiadi","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib144","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ejphar.2004.06.044","article-title":"Ionotropic GABA receptors with mixed pharmacological properties of GABAA and GABAC receptors","volume":"497","author":"Hartmann","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib145","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1523\/JNEUROSCI.22-09-03765.2002","article-title":"The GABA(A) receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors","volume":"22","author":"Harvey","year":"2002","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib146","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9568.2006.04602.x","article-title":"A local GABAergic system within rat trigeminal ganglion cells","volume":"23","author":"Hayasaki","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib147","doi-asserted-by":"crossref","first-page":"15346","DOI":"10.1074\/jbc.272.24.15346","article-title":"A novel class of GABAA receptor subunit in tissues of the reproductive system","volume":"272","author":"Hedblom","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib148","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2010.04.035","article-title":"Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding","volume":"477","author":"Hellsten","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.117.014449_bib149","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1073\/pnas.89.4.1433","article-title":"The third gamma subunit of the gamma-aminobutyric acid type A receptor family","volume":"89","author":"Herb","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1460-9568.2009.06680.x","article-title":"Inhibition of thalamic excitability by 4,5,6,7-tetrahydroisoxazolo[4,5-c]pyridine-3-ol: a selective role for delta-GABA(A) receptors","volume":"29","author":"Herd","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib151","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1523\/JNEUROSCI.5443-07.2008","article-title":"Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits","volume":"28","author":"Hevers","year":"2008","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib152","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10139","article-title":"Principles of activation and permeation in an anion-selective Cys-loop receptor","volume":"474","author":"Hibbs","year":"2011","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib153","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/sj.bjp.0700927","article-title":"Subunit-dependent interaction of the general anaesthetic etomidate with the gamma-aminobutyric acid type A receptor","volume":"120","author":"Hill-Venning","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib154","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neuropharm.2016.04.042","article-title":"Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular \u03b23+\u03b23- interface of homooligomeric \u03b23 GABAA receptors","volume":"108","author":"Hoerbelt","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib155","doi-asserted-by":"crossref","first-page":"16256","DOI":"10.1523\/JNEUROSCI.1495-14.2014","article-title":"Probing \u03b14\u03b2\u03b4 GABAA receptor heterogeneity: differential regional effects of a functionally selective \u03b14\u03b21\u03b4\/\u03b14\u03b23\u03b4 receptor agonist on tonic and phasic inhibition in rat brain","volume":"34","author":"Hoestgaard-Jensen","year":"2014","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib156","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/bph.12340","article-title":"The orthosteric GABAA receptor ligand Thio-4-PIOL displays distinctly different functional properties at synaptic and extrasynaptic receptors","volume":"170","author":"Hoestgaard-Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib157","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuroscience.2013.01.008","article-title":"Patterns of mRNA and protein expression for 12 GABAA receptor subunits in the mouse brain","volume":"236","author":"H\u00f6rtnagl","year":"2013","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib158","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2174\/1381612821666150619092720","article-title":"Novel indications for benzodiazepine antagonist flumazenil in GABA mediated pathological conditions of the central nervous system","volume":"21","author":"Hulse","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.1124\/pr.117.014449_bib159","doi-asserted-by":"crossref","first-page":"26063","DOI":"10.1074\/jbc.270.44.26063","article-title":"Chloride channel expression with the tandem construct of alpha 6-beta 2 GABAA receptor subunit requires a monomeric subunit of alpha 6 or gamma 2","volume":"270","author":"Im","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib160","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1523\/JNEUROSCI.18-07-02449.1998","article-title":"Subunit composition and quantitative importance of hetero-oligomeric receptors: GABAA receptors containing alpha6 subunits","volume":"18","author":"Jechlinger","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib161","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.bmcl.2005.12.044","article-title":"Imidazo[1,2-b][1,2,4]triazines as alpha2\/alpha3 subtype selective GABA A agonists for the treatment of anxiety","volume":"16","author":"Jennings","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/pr.117.014449_bib162","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/bph.12001","article-title":"A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors","volume":"168","author":"Jensen","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib163","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00441-005-1130-8","article-title":"Differential expression of GABAA receptor pi subunit in cultured rat alveolar epithelial cells","volume":"321","author":"Jin","year":"2005","journal-title":"Cell Tissue Res"},{"key":"10.1124\/pr.117.014449_bib164","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/bph.12127","article-title":"Advantages of an antagonist: bicuculline and other GABA antagonists","volume":"169","author":"Johnston","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0705827","article-title":"Flavonoids: some of the wisdom of sage?","volume":"142","author":"Johnston","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib166","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nm967","article-title":"Modifying quinolone antibiotics yields new anxiolytics","volume":"10","author":"Johnstone","year":"2004","journal-title":"Nat Med"},{"key":"10.1124\/pr.117.014449_bib167","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1166\/jbn.2016.2262","article-title":"First in vivo testing of compounds targeting group 3 medulloblastomas using an implantable microdevice as a new paradigm for drug development","volume":"12","author":"Jonas","year":"2016","journal-title":"J Biomed Nanotechnol"},{"key":"10.1124\/pr.117.014449_bib168","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0896-6273(95)90075-6","article-title":"Desensitized states prolong GABAA channel responses to brief agonist pulses","volume":"15","author":"Jones","year":"1995","journal-title":"Neuron"},{"key":"10.1124\/pr.117.014449_bib169","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00213-016-4506-4","article-title":"GABAA receptor occupancy by subtype selective GABAA\u03b12,3 modulators: PET studies in humans","volume":"234","author":"Jucaite","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib170","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.npp.1300239","article-title":"The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidum","volume":"28","author":"June","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.014449_bib171","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1096\/fj.02-0611fje","article-title":"General anesthetic actions in vivo strongly attenuated by a point mutation in the GABA(A) receptor beta3 subunit","volume":"17","author":"Jurd","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/pr.117.014449_bib172","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1523\/JNEUROSCI.17-20-07662.1997","article-title":"Long-lasting GABA-mediated depolarization evoked by high-frequency stimulation in pyramidal neurons of rat hippocampal slice is attributable to a network-driven, bicarbonate-dependent K+ transient","volume":"17","author":"Kaila","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib173","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrn3819","article-title":"Cation-chloride cotransporters in neuronal development, plasticity and disease","volume":"15","author":"Kaila","year":"2014","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.117.014449_bib174","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1476-5381.2011.01604.x","article-title":"2\u2032-Methoxy-6-methylflavone: a novel anxiolytic and sedative with subtype selective activating and modulating actions at GABA(A) receptors","volume":"165","author":"Karim","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib175","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.bcp.2012.05.017","article-title":"Low nanomolar GABA effects at extrasynaptic \u03b14\u03b21\/\u03b23\u03b4 GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors","volume":"84","author":"Karim","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib176","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00726-012-1456-y","article-title":"Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review","volume":"44","author":"Karim","year":"2013","journal-title":"Amino Acids"},{"key":"10.1124\/pr.117.014449_bib177","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1073\/pnas.76.2.1004","article-title":"Stimulation of benzodiazepine receptor binding by gamma-aminobutyric acid","volume":"76","author":"Karobath","year":"1979","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib178","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1111\/j.1460-9568.2010.07473.x","article-title":"Quantitative localisation of synaptic and extrasynaptic GABAA receptor subunits on hippocampal pyramidal cells by freeze-fracture replica immunolabelling","volume":"32","author":"Kasugai","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib179","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1074\/jbc.M806484200","article-title":"Unanticipated structural and functional properties of delta-subunit-containing GABAA receptors","volume":"284","author":"Kaur","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuropharm.2007.04.018","article-title":"Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity","volume":"53","author":"Khom","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib181","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1124\/mol.105.017236","article-title":"Pharmacological properties of GABAA receptors containing gamma1 subunits","volume":"69","author":"Khom","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib182","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1124\/jpet.116.232983","article-title":"Analysis of \u03b2-subunit-dependent GABAA receptor modulation and behavioral effects of valerenic acid derivatives","volume":"357","author":"Khom","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib183","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","article-title":"Reversal of pathological pain through specific spinal GABAA receptor subtypes","volume":"451","author":"Knabl","year":"2008","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib184","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0026-895X(25)09554-9","article-title":"Pharmacological modulation of the diazepam-insensitive recombinant gamma-aminobutyric acidA receptors alpha 4 beta 2 gamma 2 and alpha 6 beta 2 gamma 2","volume":"50","author":"Knoflach","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bcp.2016.03.014","article-title":"GABAA receptor-mediated neurotransmission: not so simple after all","volume":"115","author":"Knoflach","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib186","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-5793(91)81184-A","article-title":"The gamma 3-subunit of the GABAA-receptor confers sensitivity to benzodiazepine receptor ligands","volume":"293","author":"Knoflach","year":"1991","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.117.014449_bib187","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/acs.jmedchem.7b01664","article-title":"Design and synthesis of novel deuterated ligands functionally selective for the \u03b3-aminobutyric acid type A receptor (GABAAR) \u03b16 subtype with improved metabolic stability and enhanced bioavailability","volume":"61","author":"Knutson","year":"2018","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib188","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.neuropharm.2012.06.023","article-title":"Selective GABA(A) \u03b15 positive allosteric modulators improve cognitive function in aged rats with memory impairment","volume":"64","author":"Koh","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib189","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","article-title":"Drug interactions at GABA(A) receptors","volume":"67","author":"Korpi","year":"2002","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.117.014449_bib190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0026-895X(25)08539-6","article-title":"Selective antagonist for the cerebellar granule cell-specific gamma-aminobutyric acid type A receptor","volume":"47","author":"Korpi","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib191","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/sj.bjp.0700922","article-title":"Furosemide interactions with brain GABAA receptors","volume":"120","author":"Korpi","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2013.04.003","article-title":"Reduced GABAA receptor \u03b16 expression in the trigeminal ganglion enhanced myofascial nociceptive response","volume":"245","author":"Kramer","year":"2013","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib193","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0026-895X(25)08736-X","article-title":"Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties","volume":"49","author":"Krishek","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib194","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.bcp.2004.06.040","article-title":"GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic","volume":"68","author":"Krogsgaard-Larsen","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib195","doi-asserted-by":"crossref","first-page":"6936","DOI":"10.1016\/j.bmc.2008.05.049","article-title":"Affinity of 3-acyl substituted 4-quinolones at the benzodiazepine site of GABA(A) receptors","volume":"16","author":"Lager","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib196","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2005.04.030","article-title":"Isoflurane-induced surgical tolerance mediated only in part by beta3-containing GABA(A) receptors","volume":"516","author":"Lambert","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib197","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nsmb.3477","article-title":"Crystal structures of a GABAA-receptor chimera reveal new endogenous neurosteroid-binding sites","volume":"24","author":"Laverty","year":"2017","journal-title":"Nat Struct Mol Biol"},{"key":"10.1124\/pr.117.014449_bib198","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.euroneuro.2014.11.004","article-title":"Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: responsiveness and tolerance to diazepam","volume":"25","author":"Leggio","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1124\/pr.117.014449_bib199","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1101\/gr.6.6.465","article-title":"A comparative transcription map of the murine bare patches (Bpa) and striated (Str) critical regions and human Xq28","volume":"6","author":"Levin","year":"1996","journal-title":"Genome Res"},{"key":"10.1124\/pr.117.014449_bib200","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/335076a0","article-title":"Structural and functional basis for GABAA receptor heterogeneity","volume":"335","author":"Levitan","year":"1988","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib201","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1021\/jm051144x","article-title":"A pyridazine series of alpha2\/alpha3 subtype selective GABA A agonists for the treatment of anxiety","volume":"49","author":"Lewis","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib202","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1021\/acschemneuro.6b00447","article-title":"Antinociceptive effects of a novel \u03b12\/\u03b13-subtype selective GABAA receptor positive allosteric modulator","volume":"8","author":"Lewter","year":"2017","journal-title":"ACS Chem Neurosci"},{"key":"10.1124\/pr.117.014449_bib203","doi-asserted-by":"crossref","first-page":"8615","DOI":"10.1074\/jbc.M109.074708","article-title":"Numerous classes of general anesthetics inhibit etomidate binding to gamma-aminobutyric acid type A (GABAA) receptors","volume":"285","author":"Li","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib204","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1124\/mol.114.096453","article-title":"Synaptic-type \u03b11\u03b22\u03b32L GABAA receptors produce large persistent currents in the presence of ambient GABA and anesthetic drugs","volume":"87","author":"Li","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib205","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1021\/jm034164c","article-title":"Synthesis, in vitro affinity, and efficacy of a bis 8-ethynyl-4H-imidazo[1,5a]- [1,4]benzodiazepine analogue, the first bivalent alpha5 subtype selective BzR\/GABA(A) antagonist","volume":"46","author":"Li","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib206","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1007\/s00213-016-4365-z","article-title":"Hispidulin alleviated methamphetamine-induced hyperlocomotion by acting at \u03b16 subunit-containing GABAA receptors in the cerebellum","volume":"233","author":"Liao","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib207","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.ejphar.2015.07.005","article-title":"A novel GABA(A) alpha 5 receptor inhibitor with therapeutic potential","volume":"764","author":"Ling","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib208","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1073\/pnas.0502579102","article-title":"Selective anxiolysis produced by ocinaplon, a GABA(A) receptor modulator","volume":"102","author":"Lippa","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib209","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neures.2005.08.014","article-title":"Cloning and functional expression of the bovine GABA(C) rho2 subunit. Molecular evidence of a widespread distribution in the CNS","volume":"53","author":"L\u00f3pez-Ch\u00e1vez","year":"2005","journal-title":"Neurosci Res"},{"key":"10.1124\/pr.117.014449_bib210","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1523\/JNEUROSCI.20-14-05401.2000","article-title":"Selective alterations in GABAA receptor subtypes in human temporal lobe epilepsy","volume":"20","author":"Loup","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib211","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"L\u00f6w","year":"2000","journal-title":"Science"},{"key":"10.1124\/pr.117.014449_bib212","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1523\/JNEUROSCI.15-10-06957.1995","article-title":"GABA antagonists differentiate between recombinant GABAA\/benzodiazepine receptor subtypes","volume":"15","author":"L\u00fcddens","year":"1995","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib213","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0169-328X(94)90135-X","article-title":"Localization of GABAA receptor subunit mRNAs in the rat locus coeruleus","volume":"24","author":"Luque","year":"1994","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1124\/pr.117.014449_bib214","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0028-3908(03)00116-3","article-title":"The pharmacology of spontaneously open alpha 1 beta 3 epsilon GABA A receptor-ionophores","volume":"44","author":"Maksay","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib215","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fncir.2014.00027","article-title":"Delta-subunit-containing GABAA-receptors mediate tonic inhibition in paracapsular cells of the mouse amygdala","volume":"8","author":"Marowsky","year":"2014","journal-title":"Front Neural Circuits"},{"key":"10.1124\/pr.117.014449_bib216","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/157015910793358141","article-title":"An update on GABA\u03c1 receptors","volume":"8","author":"Mart\u00ednez-Delgado","year":"2010","journal-title":"Curr Neuropharmacol"},{"key":"10.1124\/pr.117.014449_bib217","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00213-003-1671-z","article-title":"A high affinity ligand for GABAA-receptor containing alpha5 subunit antagonizes ethanol\u2019s neurobehavioral effects in Long-Evans rats","volume":"172","author":"McKay","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1124\/pr.117.014449_bib218","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.117.014449_bib219","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1152\/jn.00450.2011","article-title":"Molecular basis for the high THIP\/gaboxadol sensitivity of extrasynaptic GABA(A) receptors","volume":"106","author":"Meera","year":"2011","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib220","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature13293","article-title":"Crystal structure of a human GABAA receptor","volume":"512","author":"Miller","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib221","doi-asserted-by":"crossref","first-page":"7241","DOI":"10.1523\/JNEUROSCI.1979-04.2004","article-title":"Evidence for inhibition mediated by coassembly of GABAA and GABAC receptor subunits in native central neurons","volume":"24","author":"Milligan","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib222","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s11064-013-1156-3","article-title":"Unexpected properties of \u03b4-containing GABAA receptors in response to ligands interacting with the \u03b1+ \u03b2- site","volume":"39","author":"Mirheydari","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.117.014449_bib223","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1124\/jpet.108.138859","article-title":"NS11394 [3\u2032-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a unique subtype-selective GABAA receptor positive allosteric modulator: in vitro actions, pharmacokinetic properties and in vivo anxiolytic efficacy","volume":"327","author":"Mirza","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib224","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1007\/s11064-014-1303-5","article-title":"Endogenous benzodiazepine site peptide ligands operating bidirectionally in vivo in neurogenesis and thalamic oscillations","volume":"39","author":"M\u00f6hler","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.117.014449_bib225","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1126\/science.918669","article-title":"Benzodiazepine receptor: demonstration in the central nervous system","volume":"198","author":"M\u00f6hler","year":"1977","journal-title":"Science"},{"key":"10.1124\/pr.117.014449_bib226","first-page":"4318","article-title":"cDNA cloning and expression of a gamma-aminobutyric acid A receptor epsilon-subunit in rat brain","volume":"12","author":"Moragues","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib227","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0006-8993(02)04270-1","article-title":"GABAA receptor epsilon subunit expression in identified peptidergic neurons of the rat hypothalamus","volume":"967","author":"Moragues","year":"2003","journal-title":"Brain Res"},{"key":"10.1124\/pr.117.014449_bib228","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0306-4522(02)00033-7","article-title":"Localisation of GABA(A) receptor epsilon-subunit in cholinergic and aminergic neurones and evidence for co-distribution with the theta-subunit in rat brain","volume":"111","author":"Moragues","year":"2002","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib229","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fncel.2012.00001","article-title":"GABA potency at GABA(A) receptors found in synaptic and extrasynaptic zones","volume":"6","author":"Mortensen","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"10.1124\/pr.117.014449_bib230","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1113\/jphysiol.2006.117952","article-title":"Extrasynaptic alphabeta subunit GABAA receptors on rat hippocampal pyramidal neurons","volume":"577","author":"Mortensen","year":"2006","journal-title":"J Physiol"},{"key":"10.1124\/pr.117.014449_bib231","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1523\/JNEUROSCI.23-22-07981.2003","article-title":"Modulation of GABA(A) receptors by hydrogen ions reveals synaptic GABA transient and a crucial role of the desensitization process [published correction appears in J Neurosci 2003;23]","volume":"23","author":"Mozrzymas","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib232","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroimage.2017.02.022","article-title":"GABAA receptor subtypes in the mouse brain: regional mapping and diazepam receptor occupancy by in vivo [18F]flumazenil PET","volume":"150","author":"M\u00fcller Herde","year":"2017","journal-title":"Neuroimage"},{"key":"10.1124\/pr.117.014449_bib233","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0091-3057(88)90211-0","article-title":"Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences","volume":"29","author":"Musch","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.117.014449_bib234","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/bph.13768","article-title":"GABA-\u03c1 receptors: distinctive functions and molecular pharmacology","volume":"174","author":"Naffaa","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bmc.2012.10.057","article-title":"Search for \u03b13\u03b22\/3\u03b32 subtype selective ligands that are stable on human liver microsomes","volume":"21","author":"Namjoshi","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib236","first-page":"168","article-title":"Spontaneous and gamma-aminobutyric acid (GABA)-activated GABA(A) receptor channels formed by epsilon subunit-containing isoforms","volume":"55","author":"Neelands","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib237","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0026-895X(24)23087-X","article-title":"Incorporation of the pi subunit into functional gamma-aminobutyric acid(A) receptors","volume":"56","author":"Neelands","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib238","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4155\/fmc.10.286","article-title":"Medicinal chemistry of \u03c1 GABAC receptors","volume":"3","author":"Ng","year":"2011","journal-title":"Future Med Chem"},{"key":"10.1124\/pr.117.014449_bib239","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1124\/mol.117.108563","article-title":"Rapid throughput analysis of GABAA receptor subtype modulators and blockers using DiSBAC1(3) membrane potential red dye","volume":"92","author":"Nik","year":"2017","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib240","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2826.2011.02166.x","article-title":"Translocator protein (18 kDa) as a target for novel anxiolytics with a favourable side-effect profile","volume":"24","author":"Nothdurfter","year":"2012","journal-title":"J Neuroendocrinol"},{"key":"10.1124\/pr.117.014449_bib241","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1152\/jn.2002.87.5.2624","article-title":"Selective modulation of tonic and phasic inhibitions in dentate gyrus granule cells","volume":"87","author":"Nusser","year":"2002","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib242","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1523\/JNEUROSCI.18-05-01693.1998","article-title":"Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells","volume":"18","author":"Nusser","year":"1998","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib243","first-page":"153","article-title":"Pharmacological and behavioural studies of benzodiazepine antagonists and contragonists","volume":"38","author":"Nutt","year":"1983","journal-title":"Adv Biochem Psychopharmacol"},{"key":"10.1124\/pr.117.014449_bib244","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.117.014449_bib245","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1046\/j.1460-9568.2000.00198.x","article-title":"Evidence for coassembly of mutant GABAC rho1 with GABAA gamma2S, glycine alpha1 and glycine alpha2 receptor subunits in vitro","volume":"12","author":"Pan","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib246","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0028-3908(03)00299-5","article-title":"GABAA receptor modulation by the novel intravenous general anaesthetic E-6375","volume":"45","author":"Pau","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib247","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1523\/JNEUROSCI.19-02-00578.1999","article-title":"Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses","volume":"19","author":"Perrais","year":"1999","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib248","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1124\/jpet.105.096701","article-title":"Indiplon is a high-affinity positive allosteric modulator with selectivity for alpha1 subunit-containing GABAA receptors","volume":"317","author":"Petroski","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib249","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib250","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1471-4159.2003.02135.x","article-title":"Subunit composition and quantitative importance of GABA(A) receptor subtypes in the cerebellum of mouse and rat","volume":"87","author":"P\u00f6ltl","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.117.014449_bib251","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1124\/jpet.106.107201","article-title":"The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors","volume":"319","author":"Popik","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib252","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0022-3565(25)12410-5","article-title":"Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity","volume":"276","author":"Primus","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib253","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/338582a0","article-title":"Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology","volume":"338","author":"Pritchett","year":"1989","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib254","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0026-895X(25)00452-3","article-title":"Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents","volume":"39","author":"Puia","year":"1991","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib255","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.neuroscience.2012.03.059","article-title":"Reduced GABA(A) receptor \u03b16 expression in the trigeminal ganglion alters inflammatory TMJ hypersensitivity","volume":"213","author":"Puri","year":"2012","journal-title":"Neuroscience"},{"key":"10.1124\/pr.117.014449_bib256","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fnmol.2016.00044","article-title":"Structural studies of GABAA receptor binding sites: which experimental structure tells us what?","volume":"9","author":"Puthenkalam","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"10.1124\/pr.117.014449_bib257","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1098\/rspb.1999.0941","article-title":"Response kinetics and pharmacological properties of heteromeric receptors formed by coassembly of GABA rho- and gamma 2-subunits","volume":"266","author":"Qian","year":"1999","journal-title":"Proc Biol Sci"},{"key":"10.1124\/pr.117.014449_bib258","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.neuropharm.2006.09.013","article-title":"The novel anxiolytic ELB139 displays selectivity to recombinant GABA(A) receptors different from diazepam","volume":"52","author":"Rabe","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib259","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1038\/ncomms7803","article-title":"Analgesia and unwanted benzodiazepine effects in point-mutated mice expressing only one benzodiazepine-sensitive GABAA receptor subtype","volume":"6","author":"Ralvenius","year":"2015","journal-title":"Nat Commun"},{"key":"10.1124\/pr.117.014449_bib260","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2174\/0929867321666141106110356","article-title":"GABA(A) receptor subtype-selectivity of novel bicuculline derivatives","volume":"22","author":"Ramerstorfer","year":"2015","journal-title":"Curr Med Chem"},{"key":"10.1124\/pr.117.014449_bib261","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor alpha+beta- interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib262","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejphar.2010.03.015","article-title":"The point mutation gamma 2F77I changes the potency and efficacy of benzodiazepine site ligands in different GABAA receptor subtypes","volume":"636","author":"Ramerstorfer","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib263","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2210-6-1","article-title":"Impact of epsilon and theta subunits on pharmacological properties of alpha3beta1 GABAA receptors expressed in Xenopus oocytes","volume":"6","author":"Ranna","year":"2006","journal-title":"BMC Pharmacol"},{"key":"10.1124\/pr.117.014449_bib264","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bcp.2009.12.024","article-title":"GABA(A) receptor subtype selectivity underlying anxiolytic effect of 6-hydroxyflavone","volume":"79","author":"Ren","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib265","doi-asserted-by":"crossref","first-page":"8608","DOI":"10.1523\/JNEUROSCI.23-24-08608.2003","article-title":"Sedation and anesthesia mediated by distinct GABA(A) receptor isoforms","volume":"23","author":"Reynolds","year":"2003","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib266","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nchembio.917","article-title":"Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands","volume":"8","author":"Richter","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1124\/pr.117.014449_bib267","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1021\/jm801652d","article-title":"Antiseizure activity of novel gamma-aminobutyric acid (A) receptor subtype-selective benzodiazepine analogues in mice and rat models","volume":"52","author":"Rivas","year":"2009","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib268","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib269","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.117.014449_bib270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-011613-135947","article-title":"GABAA receptor subtypes: therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism","volume":"54","author":"Rudolph","year":"2014","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/pr.117.014449_bib271","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1152\/jn.2000.84.2.771","article-title":"Postsynaptic receptor occupancy during evoked transmission at striatal GABAergic synapses in vitro","volume":"84","author":"Rumpel","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib272","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s40263-013-0129-z","article-title":"The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy","volume":"28","author":"Rundfeldt","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1124\/pr.117.014449_bib273","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0026-895X(25)08530-X","article-title":"Novel properties of homomeric beta 1 gamma-aminobutyric acid type A receptors: actions of the anesthetics propofol and pentobarbital","volume":"47","author":"Sanna","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib274","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1074\/jbc.M709993200","article-title":"Histamine action on vertebrate GABAA receptors: direct channel gating and potentiation of GABA responses","volume":"283","author":"Saras","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib275","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2008.02.020","article-title":"PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats","volume":"1208","author":"Savi\u0107","year":"2008","journal-title":"Brain Res"},{"key":"10.1124\/pr.117.014449_bib276","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/sj.npp.1301403","article-title":"Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?","volume":"33","author":"Savi\u0107","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.117.014449_bib277","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","article-title":"Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?","volume":"34","author":"Savi\u0107","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.117.014449_bib278","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pbb.2004.07.013","article-title":"Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt","volume":"79","author":"Savi\u0107","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1124\/pr.117.014449_bib279","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0028-3908(99)00253-1","article-title":"Modulation of GABAergic synaptic transmission by the non-benzodiazepine anxiolytic etifoxine","volume":"39","author":"Schlichter","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib280","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/328221a0","article-title":"Sequence and functional expression of the GABA A receptor shows a ligand-gated receptor super-family","volume":"328","author":"Schofield","year":"1987","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib281","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.bcp.2012.04.008","article-title":"Histaminergic pharmacology of homo-oligomeric \u03b23 \u03b3-aminobutyric acid type A receptors characterized by surface plasmon resonance biosensor technology","volume":"84","author":"Seeger","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.117.014449_bib282","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.apha.2014.10.006","article-title":"Inhibitory neurosteroids and the GABAA receptor","volume":"72","author":"Seljeset","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.117.014449_bib283","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1021\/jm058002n","article-title":"A novel selective GABA(A) alpha1 receptor agonist displaying sedative and anxiolytic-like properties in rodents","volume":"48","author":"Selleri","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib284","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1021\/jm020999w","article-title":"Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands","volume":"46","author":"Selleri","year":"2003","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1523\/JNEUROSCI.3209-04.2005","article-title":"Pharmacological properties of GABAA receptors in rat hypothalamic neurons expressing the epsilon-subunit","volume":"25","author":"Sergeeva","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib286","doi-asserted-by":"crossref","first-page":"23985","DOI":"10.1074\/jbc.M110.103309","article-title":"Fragrant dioxane derivatives identify beta1-subunit-containing GABAA receptors","volume":"285","author":"Sergeeva","year":"2010","journal-title":"J Biol Chem"},{"issue":"Pt B","key":"10.1124\/pr.117.014449_bib287","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2016.01.020","article-title":"Role of \u03b14-containing GABAA receptors in limiting synaptic plasticity and spatial learning of female mice during the pubertal period","volume":"1654","author":"Shen","year":"2017","journal-title":"Brain Res"},{"key":"10.1124\/pr.117.014449_bib288","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology of \u03b3-aminobutyric acidA receptor subtypes","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol Rev"},{"key":"10.1124\/pr.117.014449_bib289","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv Pharmacol"},{"key":"10.1124\/pr.117.014449_bib290","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/286285a0","article-title":"Molecular heterogeneity of benzodiazepine receptors","volume":"286","author":"Sieghart","year":"1980","journal-title":"Nature"},{"key":"10.1124\/pr.117.014449_bib291","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr Top Med Chem"},{"key":"10.1124\/pr.117.014449_bib292","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-5793(89)81576-5","article-title":"The rat beta 1-subunit of the GABAA receptor forms a picrotoxin-sensitive anion channel open in the absence of GABA","volume":"257","author":"Sigel","year":"1989","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.117.014449_bib293","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0165-6147(97)90675-1","article-title":"The benzodiazepine binding site of GABAA receptors","volume":"18","author":"Sigel","year":"1997","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.117.014449_bib294","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1038\/s41598-017-05757-4","article-title":"Molecular tools for GABAA receptors: high affinity ligands for \u03b21-containing subtypes","volume":"7","author":"Simeone","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pr.117.014449_bib295","doi-asserted-by":"crossref","first-page":"3588","DOI":"10.1523\/JNEUROSCI.20-10-03588.2000","article-title":"GABA(A) receptor epsilon and theta subunits display unusual structural variation between species and are enriched in the rat locus ceruleus","volume":"20","author":"Sinkkonen","year":"2000","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib296","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.tips.2012.08.003","article-title":"Anxioselective anxiolytics: on a quest for the Holy Grail","volume":"33","author":"Skolnick","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.117.014449_bib297","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0026-895X(25)10485-9","article-title":"Rat beta 3 subunits expressed in human embryonic kidney 293 cells form high affinity [35S]t-butylbicyclophosphorothionate binding sites modulated by several allosteric ligands of gamma-aminobutyric acid type A receptors","volume":"48","author":"Slany","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib298","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/jpet.104.070342","article-title":"Compounds exhibiting selective efficacy for different beta subunits of human recombinant gamma-aminobutyric acid A receptors","volume":"311","author":"Smith","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib299","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(00)89009-4","article-title":"Functional domains of GABAA receptors","volume":"16","author":"Smith","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/pr.117.014449_bib300","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejphar.2016.09.016","article-title":"Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the \u03b15 subunit","volume":"791","author":"Stameni\u0107","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib301","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cne.24337","article-title":"GABAA receptor subunits in the human amygdala and hippocampus: immunohistochemical distribution of 7 subunits","volume":"526","author":"Stefanits","year":"2018","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.117.014449_bib302","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0026-895X(25)10583-X","article-title":"beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site","volume":"48","author":"Stevenson","year":"1995","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib303","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/cne.23923","article-title":"The \u03b11, \u03b12, \u03b13, and \u03b32 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development","volume":"524","author":"Stojanovic","year":"2016","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.117.014449_bib304","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1021\/jm0407613","article-title":"Synthesis and biological evaluation of 3-heterocyclyl-7,8,9,10-tetrahydro-(7,10-ethano)-1,2,4-triazolo[3,4-a]phthalazines and analogues as subtype-selective inverse agonists for the GABA(A)alpha5 benzodiazepine binding site","volume":"47","author":"Street","year":"2004","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib305","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.104.071282","article-title":"Characterization of the interaction of indiplon, a novel pyrazolopyrimidine sedative-hypnotic, with the GABAA receptor","volume":"311","author":"Sullivan","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib306","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/jpet.107.121525","article-title":"Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction","volume":"322","author":"Summerfield","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib307","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1124\/mol.54.5.928","article-title":"Rat and human hippocampal alpha5 subunit-containing gamma-aminobutyric AcidA receptors have alpha5 beta3 gamma2 pharmacological characteristics","volume":"54","author":"Sur","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib308","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbamcr.2011.05.003","article-title":"Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells","volume":"1813","author":"Takahashi","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.117.014449_bib309","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1152\/jn.00801.2009","article-title":"Modulation of spontaneous and GABA-evoked tonic alpha4beta3delta and alpha4beta3gamma2L GABAA receptor currents by protein kinase A","volume":"103","author":"Tang","year":"2010","journal-title":"J Neurophysiol"},{"key":"10.1124\/pr.117.014449_bib310","doi-asserted-by":"crossref","first-page":"7516","DOI":"10.1016\/j.bmc.2008.04.067","article-title":"Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor","volume":"16","author":"Tarrag\u00f3","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib311","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bjp.0703558","article-title":"A novel positive allosteric modulator of the GABA(A) receptor: the action of (+)-ROD188","volume":"131","author":"Thomet","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib312","first-page":"993","article-title":"Residues in transmembrane domains I and II determine gamma-aminobutyric acid type A receptor subtype-selective antagonism by furosemide","volume":"55","author":"Thompson","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib313","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0028-3908(02)00162-4","article-title":"Overexpression of the GABA(A) receptor epsilon subunit results in insensitivity to anaesthetics","volume":"43","author":"Thompson","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib314","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/sj.bjp.0705689","article-title":"Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors","volume":"142","author":"Thompson","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib315","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0026-895X(24)12337-1","article-title":"Tracazolate reveals a novel type of allosteric interaction with recombinant gamma-aminobutyric acid(A) receptors","volume":"61","author":"Thompson","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib316","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1523\/JNEUROSCI.17-08-02728.1997","article-title":"Stoichiometry and assembly of a recombinant GABAA receptor subtype","volume":"17","author":"Tretter","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib317","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/bph.14087","article-title":"Towards functional selectivity for \u03b16\u03b23\u03b32 GABAA receptors: a series of novel pyrazoloquinolinones","volume":"175","author":"Treven","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib318","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10606820308252","article-title":"High throughput electrophysiology using a fully automated, multiplexed recording system","volume":"9","author":"Trumbull","year":"2003","journal-title":"Receptors Channels"},{"key":"10.1124\/pr.117.014449_bib319","doi-asserted-by":"crossref","first-page":"6004","DOI":"10.1021\/jm050249x","article-title":"A new pyridazine series of GABAA alpha5 ligands","volume":"48","author":"van Niel","year":"2005","journal-title":"J Med Chem"},{"key":"10.1124\/pr.117.014449_bib320","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/bph.12153","article-title":"Subtype selectivity of \u03b1+\u03b2- site ligands of GABAA receptors: identification of the first highly specific positive modulators at \u03b16\u03b22\/3\u03b32 receptors","volume":"169","author":"Varagic","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib321","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bph.12151","article-title":"Identification of novel positive allosteric modulators and null modulators at the GABAA receptor \u03b1+\u03b2- interface","volume":"169","author":"Varagic","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib322","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1517\/13543784.2010.513382","article-title":"The inhibitory GABA system as a therapeutic target for cognitive symptoms in schizophrenia: investigational agents in the pipeline","volume":"19","author":"Vinkers","year":"2010","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1124\/pr.117.014449_bib323","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0896-6273(94)90330-1","article-title":"A novel allosteric modulatory site on the GABAA receptor beta subunit","volume":"12","author":"Wafford","year":"1994","journal-title":"Neuron"},{"key":"10.1124\/pr.117.014449_bib324","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0026-895X(25)13199-4","article-title":"Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA\/benzodiazepine receptors","volume":"44","author":"Wafford","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib325","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coph.2005.10.004","article-title":"Gaboxadol--a new awakening in sleep","volume":"6","author":"Wafford","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/pr.117.014449_bib326","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0026-895X(25)09339-3","article-title":"Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit","volume":"50","author":"Wafford","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.117.014449_bib327","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2008.08.004","article-title":"Novel compounds selectively enhance delta subunit containing GABA A receptors and increase tonic currents in thalamus","volume":"56","author":"Wafford","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib328","doi-asserted-by":"crossref","first-page":"10462","DOI":"10.1523\/JNEUROSCI.1658-05.2005","article-title":"Kinetics and spontaneous open probability conferred by the epsilon subunit of the GABAA receptor","volume":"25","author":"Wagner","year":"2005","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib329","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/(SICI)1096-9861(19991220)415:3<313::AID-CNE2>3.0.CO;2-7","article-title":"Regional and cellular localisation of GABA(A) receptor subunits in the human basal ganglia: an autoradiographic and immunohistochemical study","volume":"415","author":"Waldvogel","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.117.014449_bib330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.biopsych.2015.12.016","article-title":"A human open field test reveals thigmotaxis related to agoraphobic fear","volume":"80","author":"Walz","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1124\/pr.117.014449_bib331","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.neuropharm.2008.07.040","article-title":"GABA A receptor subtype selectivity underlying selective anxiolytic effect of baicalin","volume":"55","author":"Wang","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib332","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1460-9568.1998.00023.x","article-title":"Distribution of GABA receptor rho subunit transcripts in the rat brain","volume":"10","author":"Wegelius","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib333","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1523\/JNEUROSCI.17-13-05027.1997","article-title":"Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties. [erratum to be published]","volume":"17","author":"Whiting","year":"1997","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib334","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-3565(25)23683-7","article-title":"CGS 20625, a novel pyrazolopyridine anxiolytic","volume":"248","author":"Williams","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.117.014449_bib335","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1073\/pnas.91.10.4569","article-title":"The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit","volume":"91","author":"Wingrove","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.117.014449_bib336","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1523\/JNEUROSCI.12-03-01040.1992","article-title":"The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon","volume":"12","author":"Wisden","year":"1992","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib337","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1523\/JNEUROSCI.4193-12.2013","article-title":"GABA-independent GABAA receptor openings maintain tonic currents","volume":"33","author":"Wlodarczyk","year":"2013","journal-title":"J Neurosci"},{"key":"10.1124\/pr.117.014449_bib338","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.1074\/jbc.M116.738906","article-title":"Toward understanding functional properties and subunit arrangement of \u03b14\u03b22\u03b4 \u03b3-aminobutyric acid, type A (GABAA) receptors","volume":"291","author":"Wongsamitkul","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.117.014449_bib339","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1111\/j.1460-9568.1997.tb01641.x","article-title":"Pharmacological and physiological characterization of murine homomeric beta3 GABA(A) receptors","volume":"9","author":"Wooltorton","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1124\/pr.117.014449_bib340","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbr.2016.07.002","article-title":"The essential role of hippocampal alpha6 subunit-containing GABAA receptors in maternal separation stress-induced adolescent depressive behaviors","volume":"313","author":"Yang","year":"2016","journal-title":"Behav Brain Res"},{"key":"10.1124\/pr.117.014449_bib341","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00424-011-0988-4","article-title":"GABAA receptors involved in sleep and anaesthesia: \u03b21- versus \u03b23-containing assemblies","volume":"463","author":"Yanovsky","year":"2012","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.117.014449_bib342","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3389\/fncir.2013.00203","article-title":"The contribution of \u03b4 subunit-containing GABAA receptors to phasic and tonic conductance changes in cerebellum, thalamus and neocortex","volume":"7","author":"Ye","year":"2013","journal-title":"Front Neural Circuits"},{"key":"10.1124\/pr.117.014449_bib343","doi-asserted-by":"crossref","first-page":"7548","DOI":"10.1016\/j.bmc.2010.08.049","article-title":"Design, synthesis, and subtype selectivity of 3,6-disubstituted \u03b2-carbolines at Bz\/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse","volume":"18","author":"Yin","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1124\/pr.117.014449_bib344","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/j.1460-2075.1990.tb07525.x","article-title":"Structural and functional characterization of the gamma 1 subunit of GABAA\/benzodiazepine receptors","volume":"9","author":"Ymer","year":"1990","journal-title":"EMBO J"},{"key":"10.1124\/pr.117.014449_bib345","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1165\/rcmb.2015-0176OC","article-title":"Targeting the \u03b3-aminobutyric acid A receptor \u03b14 subunit in airway smooth muscle to alleviate bronchoconstriction","volume":"54","author":"Yocum","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pr.117.014449_bib346","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/0269881113507643","article-title":"Limited central side effects of a \u03b2-subunit subtype-selective GABAA receptor allosteric modulator","volume":"28","author":"Yoshimura","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1124\/pr.117.014449_bib347","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.neuropharm.2010.07.011","article-title":"Benzodiazepine modulation of the rat GABAA receptor \u03b14\u03b23\u03b32L subtype expressed in Xenopus oocytes","volume":"59","author":"You","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.117.014449_bib348","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2210-7-2","article-title":"Mapping the contribution of beta3-containing GABAA receptors to volatile and intravenous general anesthetic actions","volume":"7","author":"Zeller","year":"2007","journal-title":"BMC Pharmacol"},{"key":"10.1124\/pr.117.014449_bib349","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1096\/fj.04-3443fje","article-title":"Distinct molecular targets for the central respiratory and cardiac actions of the general anesthetics etomidate and propofol","volume":"19","author":"Zeller","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/pr.117.014449_bib350","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-2999(96)00066-0","article-title":"Interaction of allosteric ligands with GABAA receptors containing one, two, or three different subunits","volume":"301","author":"Zezula","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.117.014449_bib351","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/sj.bjp.0707665","article-title":"alpha1beta2delta, a silent GABAA receptor: recruitment by tracazolate and neurosteroids","volume":"153","author":"Zheleznova","year":"2008","journal-title":"Br J Pharmacol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724012705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.117.014449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T06:04:03Z","timestamp":1739858643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724012705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":352,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0031699724012705"],"URL":"https:\/\/doi.org\/10.1124\/pr.117.014449","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734202313.793556508","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.734202313.793551612","asserted-by":"object"}]},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.117.014449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}